GNTA
Income statement / Annual
Last year (2025), Genenta Science SpA's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Genenta Science SpA's net income was -$6.27 M.
See Genenta Science SpA,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$26.97 K
|
$46.51 K
|
$41.71 K
|
$6.00 K
|
$5.10 K
|
$1.77 K
|
$0.00
|
| Gross Profit |
-$26.97 K
|
-$46.51 K
|
-$41.71 K
|
-$6.00 K
|
-$5.10 K
|
-$1.77 K
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$2.59 M
|
$5.03 M
|
$6.36 M
|
$5.21 M
|
$3.53 M
|
$4.36 M
|
$3.65 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.72 M
|
$5.13 M
|
$5.12 M
|
$5.57 M
|
$2.39 M
|
$837.35 K
|
$908.43 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$6.32 M
|
$10.15 M
|
$11.48 M
|
$10.78 M
|
$5.92 M
|
$5.20 M
|
$4.56 M
|
| Cost And Expenses |
$6.34 M
|
$10.20 M
|
$11.53 M
|
$10.79 M
|
$5.93 M
|
$5.20 M
|
$4.56 M
|
| Interest Income |
$968.70 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$384.21 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$26.97 K
|
$46.51 K
|
$41.71 K
|
$6.00 K
|
$5.10 K
|
$1.77 K
|
$0.00
|
| EBITDA |
-$6.32 M |
-$10.15 M |
-$11.48 M |
-$10.78 M |
-$5.92 M |
-$5.20 M |
-$4.56 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$71.00 K
|
$889.80 K
|
$85.95 K
|
$2.51 M
|
$164.65 K
|
-$1.66 K
|
$26.40 K
|
| Income Before Tax |
-$6.27 M
|
-$9.31 M
|
-$11.44 M
|
-$8.28 M
|
-$5.76 M
|
-$5.20 M
|
-$4.53 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$6.27 M
|
-$9.31 M
|
-$11.44 M
|
-$8.28 M
|
-$5.76 M
|
-$5.20 M
|
-$4.53 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.33 |
-0.49 |
-0.64 |
-0.47 |
-0.31 |
-0.31 |
-0.25 |
| EPS Diluted |
-0.33 |
-0.49 |
-0.64 |
-0.47 |
-0.31 |
-0.31 |
-0.25 |
| Weighted Average Shares Out |
$19.71 M
|
$18.27 M
|
$18.22 M
|
$18.22 M
|
$18.22 M
|
$18.12 M
|
$18.12 M
|
| Weighted Average Shares Out Diluted |
$19.71 M
|
$18.27 M
|
$18.22 M
|
$18.22 M
|
$18.22 M
|
$18.12 M
|
$18.12 M
|
| Link |
|
|
|
|
|
|
|
